VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

The Effects of a Music Therapist Designed Listening Program on Intraoperative Vitrectomy

Not Applicable

Completed

Conditions: Pain, Postoperative
Music Therapy

Interventions: Behavioral: vitrectomy with music listening

First Posted Date: 2017-05-10

Last Posted Date: 2018-05-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 57

Registration Number: NCT03147235

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Effect of Pectoralis Block on Analgesia After Simple Mastectomy

Phase 4

Withdrawn

Conditions: Mastectomy
Nerve Block
Analgesia, Postoperative

Interventions: Procedure: Pectoralis block
Drug: Ropivacaine Injection
Drug: Normal saline injection

First Posted Date: 2017-05-08

Last Posted Date: 2018-08-14

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT03143530

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Competency-based Approaches to Community Health

Not Applicable

Completed

Conditions: Obesity, Childhood

First Posted Date: 2017-05-04

Last Posted Date: 2020-03-20

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 117

Registration Number: NCT03141151

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy

Not Applicable

Completed

Conditions: Colonoscopy
Ventilation
Oxygenation

Interventions: Device: Oxygen via SuperNO2VA nasal mask
Device: Oxygen via nasal cannula

First Posted Date: 2017-05-04

Last Posted Date: 2019-02-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 174

Registration Number: NCT03139448

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Vagal Stimulation in POTS

Phase 1

Active, not recruiting

Conditions: Postural Tachycardia Syndrome

Interventions: Drug: Galantamine Pill
Drug: placebo sugar pill
Drug: Pyridostigmine Pill
Device: Vagal stimulation
Device: Sham vagal stimulation

First Posted Date: 2017-04-21

Last Posted Date: 2024-07-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 11

Registration Number: NCT03124355

Locations: 🇺🇸
Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville, Tennessee, United States

Vanderbilt ICU Recovery Program Pilot Trial

Not Applicable

Completed

Conditions: Intensive Care Unit Syndrome
Intensive Care (ICU) Myopathy
Intensive Care Psychiatric Disorder (Diagnosis)
Intensive Care Neurological Disorder

Interventions: Other: VANDERBILT ICU RECOVERY PROGRAM

First Posted Date: 2017-04-21

Last Posted Date: 2019-10-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 232

Registration Number: NCT03124342

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Human Immunome Program

Completed

Conditions: Healthy

First Posted Date: 2017-04-18

Last Posted Date: 2021-02-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2

Registration Number: NCT03118687

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Norepinephrine-targeted Therapy for Action Control in Parkinson Disease

Phase 4

Completed

Conditions: Parkinson Disease

Interventions: Drug: Droxidopa
Drug: Carbidopa

First Posted Date: 2017-04-14

Last Posted Date: 2020-01-27

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 15

Registration Number: NCT03115827

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Measuring Outcomes of Activity in Intensive Care

Active, not recruiting

Conditions: Mechanical Ventilation
Physical Activity
Disability Physical
Muscle Weakness
Critical Illness
Sepsis
Cognitive Impairment

First Posted Date: 2017-04-14

Last Posted Date: 2024-01-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 312

Registration Number: NCT03115840

Locations: 🇺🇸
The Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function

Phase 4

Completed

Conditions: High Blood Pressure

Interventions: Drug: Aliskiren 150 mg
Drug: Placebo
Drug: HCTZ
Drug: Aliskiren 300 mg

First Posted Date: 2017-04-14

Last Posted Date: 2017-08-25

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 31

Registration Number: NCT03115853

Locations: 🇺🇸
VUMC, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy